Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication in laryngopharyngeal reflux
2004-001633-42Phase 4Terminated
- Sponsor
- NHS Grampian
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lansoprazole, clarithromycin and amoxicillin in laryngopharyngeal reflux (LPR) and Helicobacter pylori infection (2 arms), sponsored by NHS Grampian. Primary endpoint: Positive urea breath test. Started Feb 2005; status: terminated.
02
Drugs
lansoprazoleclarithromycinamoxicillin
03
Conditions
laryngopharyngeal reflux (LPR)Helicobacter pylori infection
Beyond the preview
Go deeper on 2004-001633-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001633-42.